Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Attributable Disease Burden Related to Low Bone Mineral Density in Iran From 1990 to 2019: Results From the Global Burden of Disease 2019 Publisher Pubmed



Azangoukhyavy M1 ; Saeedi Moghaddam S1 ; Mohammadi E1, 2 ; Shobeiri P1 ; Rashidi MM1 ; Ahmadi N1 ; Shahsavan S1 ; Shirzad Moghaddam Z1 ; Sohrabi H1 ; Pourghasem F1 ; Kalantar R1 ; Ghaffari A1 ; Hashemi SM1 ; Rezaei N1, 3 Show All Authors
Authors
  1. Azangoukhyavy M1
  2. Saeedi Moghaddam S1
  3. Mohammadi E1, 2
  4. Shobeiri P1
  5. Rashidi MM1
  6. Ahmadi N1
  7. Shahsavan S1
  8. Shirzad Moghaddam Z1
  9. Sohrabi H1
  10. Pourghasem F1
  11. Kalantar R1
  12. Ghaffari A1
  13. Hashemi SM1
  14. Rezaei N1, 3
  15. Larijani B3
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Osteoporosis Published:2022


Abstract

Purpose: Low bone mineral density (BMD) including low bone mass and osteoporosis is a bone state that carries the risk of fractures and the consequent burden. Since Iran has an aging population and is considered a high-risk country regarding fracture, the objective of this study was to report the low BMD attributable burden in Iran from 1990 to 2019 at national and subnational levels. Materials and methods: In this study, the Global Burden of Disease (GBD) study 2019 estimates of exposure value and attributable burden were used. For each risk-outcome pair, following the estimation of relative risk, exposure level, and the Theoretical Minimum Risk Exposure Level (TMREL), the Population Attributable Fractions (PAFs) and attributable burden were computed. The Summary Exposure Value (SEV) index was also computed. Results: Although the age-standardized DALYs and deaths decreased (− 41.0 [95% uncertainty interval: − 45.7 to − 33.2] and − 43.3 [− 48.9 to − 32.5]), attributable all age numbers in Iran increased from 1990 to 2019 (64.3 [50.6 to 89.1] and 66.8 [49.7 to 102.0]). The male gender had a higher low BMD attributed burden in Iran at national and subnational levels except for Tehran. Among low BMD-associated outcomes, motor vehicle road injuries and falls accounted for most of the low BMD-attributed burden in Iran. The SEV for low BMD remained constant from 1990 to 2019 in the country and females had higher SEVs. Conclusion: Low BMD and the associated outcomes has to gain attention in Iran’s health system due to an aging population. Hence, timely interventions by health systems and the population at stake might assist in reducing the burden attributed to low BMD. © 2022, International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.
Related Docs
View other Related Docs
1. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
2. Measuring Routine Childhood Vaccination Coverage in 204 Countries and Territories, 1980–2019: A Systematic Analysis for the Global Burden of Disease Study 2020, Release 1, The Lancet (2021)
3. Regional Burden of Chronic Kidney Disease in North Africa and Middle East During 1990–2019; Results From Global Burden of Disease Study 2019, Frontiers in Public Health (2022)
4. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
5. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
6. Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019, International Journal of Cardiology (2022)
7. Estimating Mortality and Disability in Peru Before the Covid-19 Pandemic: A Systematic Analysis From the Global Burden of the Disease Study 2019, Frontiers in Public Health (2023)
8. Particulate Matter Pollution Remains a Threat for Cardiovascular Health: Findings From the Global Burden of Disease 2019, Journal of the American Heart Association (2023)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (47)
Bagher Larijani (42)
Other Related Docs
9. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
10. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)
11. Iranian Multi-Center Osteoporosis Study (Imos), 2021–2022: The Study Protocol, BMC Geriatrics (2022)
12. The Burden of Neck Pain Among Adults Aged 70 Years and Older in Iran, 1990–2019, Health Science Reports (2023)
13. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
14. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
15. Global, Regional, and National Burden of Bone Fractures in 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2021)
16. “Current Incidence of Injuries in Iran; Findings of Steps Survey 2021”, Heliyon (2023)
17. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, Chest (2022)
18. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
19. Global, Regional, and National Sex Differences in the Global Burden of Tuberculosis by Hiv Status, 1990–2019: Results From the Global Burden of Disease Study 2019, The Lancet Infectious Diseases (2022)
20. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
21. Global Mortality of Snakebite Envenoming Between 1990 and 2019, Nature Communications (2022)
22. Global, Regional, and National Burden of Rheumatoid Arthritis, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
23. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
24. Burden of Road Traffic Injuries in Iran: A National and Subnational Perspective, 1990-2019, Injury Prevention (2023)
25. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
26. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
27. Quality of Care of Peptic Ulcer Disease Worldwide: A Systematic Analysis for the Global Burden of Disease Study 1990-2019, PLoS ONE (2022)
28. Low Bone Mineral Density, a Neglected Condition in North Africa and Middle East: Estimates From the Global Burden of Disease Study, 1990–2019, Osteoporosis International (2023)
29. National and Sub-National Burden and Trend of Type 1 Diabetes in 31 Provinces of Iran, 1990–2019, Scientific Reports (2023)
30. Prediction of Human Health Risk and Disability-Adjusted Life Years Induced by Heavy Metals Exposure Through Drinking Water in Fars Province, Iran, Scientific Reports (2023)
31. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
32. National, Subnational and Risk Attributed Burden of Chronic Respiratory Diseases in Iran From 1990 to 2019, Respiratory Research (2023)
33. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
34. Age–Sex Differences in the Global Burden of Lower Respiratory Infections and Risk Factors, 1990–2019: Results From the Global Burden of Disease Study 2019, The Lancet Infectious Diseases (2022)
35. Measuring the Availability of Human Resources for Health and Its Relationship to Universal Health Coverage for 204 Countries and Territories From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
36. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
37. Iran’S Health System Performance in Achieving Goals Based on the World Health Organization’S Framework: A Scoping Review, Journal of Research and Health (2022)
38. Global, Regional, and National Burden of Cancers Attributable to Excess Body Weight in 204 Countries and Territories, 1990 to 2019, Obesity (2022)
39. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019, The BMJ (2022)
40. Global, Regional, and National Mortality Due to Unintentional Carbon Monoxide Poisoning, 2000–2021: Results From the Global Burden of Disease Study 2021, The Lancet Public Health (2023)
41. The Burden of Type 2 Diabetes Mellitus and Attributable Risk Factors in Iran, 1990–2019: Results From the Global Burden of Disease Study 2019, Iranian Journal of Public Health (2024)
42. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
43. The Burden of Gout and Its Attributable Risk Factors in the Middle East and North Africa Region, 1990 to 2019, Journal of Rheumatology (2023)
44. Burden of Hand Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Journal of Hand Surgery (2023)
45. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
46. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
47. Global, Regional, and National Sex-Specific Burden and Control of the Hiv Epidemic, 1990–2019, for 204 Countries and Territories: The Global Burden of Diseases Study 2019, The Lancet HIV (2021)
48. Increasing Burden of Hip Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Archives of Orthopaedic and Trauma Surgery (2023)
49. Iran Osteoporosis Registry: Protocol for Nationwide Study, Journal of Diabetes and Metabolic Disorders (2023)
50. Burden of Tracheal, Bronchus, and Lung Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019, Journal of Thoracic Oncology (2021)